CONSTELLATION TECHNOLOGIES LIMITED — Declaration of Voting Results & Voting Rights Announcements 2015

May 31, 2015

==> picture [100 x 86] intentionally omitted <==

ASX Announcement

Resignation and Appointment of Director

Melbourne, Australia, 1 June 2015: Agenix advised that Mr Nicholas Weston has resigned as Executive Chairman and Director effective today. Mr Weston will remain a Director of the Group’s wholly owned China subsidiary, Agenix Biopharmaceutical (Shanghai) Company Limited in order to complete the repatriation of funds from China previously announced.

The Board takes this opportunity to thank Mr Weston for his tireless efforts and dedication in is his role as Executive Chair.

Mr Weston will continue to assist the company as a trusted and respected legal advisor.

Mr Craig Chapman will act a Non-Executive Chairman.

Agenix advises that Mr Adam Gallagher has been appointed a Non-Executive Director of the Company and its Australian Subsidiaries. Mr Gallagher has completed his Masters of Commerce at the University of Queensland, holds a degree in Economics and diplomas in Information Systems, Applied Corporate Governance and Financial Planning. Mr Gallagher is a Director of Scintilla Strategic Investments Limited, an ASX Microcap investment company. Scintilla is a major shareholder of the Company.

Mr Gallagher is a Director and Company Secretary of Pacific Environment Limited (ASX:PEH).

For further information please contact:

Gary Taylor Company Secretary Agenix Limited Tel: +61 (0) 430 432 745

Page 1 of 2

==> picture [66 x 64] intentionally omitted <==

AGENIX LIMITED

RESULTS OF EXTRAORDINARY GENERAL MEETING

12 May 2015

As required by section 251AA (2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda.

						Manner in which the votes were cast in person or by proxy	Manner in which the votes were cast in person or by proxy	Manner in which the votes were cast in person or by proxy
		Manner in which the securityholder directed the proxy vote (as at proxy close)					on a poll
	**Resolution **	VotesFor	VotesAgainst	VotesDiscretionary	VotesAbstain	For	Against	Abstain*
	Issue of Securities to	44,844,190	2,079,703	12,925,013	75	57,769,203	2,079,703	75
1	OKSAGX Inc.
						96.53%	3.47%
	Assignment of
	Thromboview® to	44,844,190	2,079,703	12,925,013	75	57,769,203	2,079,703	75
2	OKSAGX Inc.
						96.53%	3.47%

• Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item

Page 2 of 2